Cyclerion Therapeutics, Inc. · NASDAQ:CYCN
Tyndall Capital Partners L P reported a 5.10% stake in Cyclerion Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Tyndall Capital Partners L P reported a 5.10% stake in Cyclerion Therapeutics, Inc., 164,777 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 5.10%
- Shares
- 164,777
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Tyndall Capital Partners, L.P. | 5.10% | 164,777 |
Source
Related
- Cyclerion Therapeutics, Inc.
- Tyndall Capital Partners L P
- Cyclerion Therapeutics, Inc. shareholders
- Schedule 13G/A · Tyndall Capital Partners L P · Aug 14, 2025
- Form 4 · Chicko Rhonda M. · Aug 18, 2026
- Form 4 · Graul Regina Margaret · Aug 18, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026
- Form 4 · Peter M. Hecht · Jul 20, 2026